Company Telferscot Resources Inc Canadian Securities Exchange
Equities
TFS
CA87957T1066
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | - |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoids and Terpenes
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-04-19 | |
President | 56 | 16-04-19 | |
Chief Tech/Sci/R&D Officer | - | 20-05-14 | |
Barry Polisuk
BRD | Director/Board Member | 61 | 18-04-10 |
Frank Candido
IRC | Investor Relations Contact | 59 | 18-08-31 |
Eric Malinski
SAM | Sales & Marketing | - | 18-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 56 | 16-04-19 | |
Barry Polisuk
BRD | Director/Board Member | 61 | 18-04-10 |
Vitor Fonseca
BRD | Director/Board Member | 71 | 18-04-10 |
Chief Executive Officer | 63 | 16-04-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,909,159 | 33,562,159 ( 86.26 %) | 0 | 86.26 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+42.64% | 6.28B | |
-15.52% | 4.51B | |
+8.35% | 3.35B | |
-11.10% | 3.13B | |
-4.12% | 2.47B | |
+46.46% | 1.96B | |
-7.97% | 1.68B | |
-1.07% | 1.63B | |
-11.56% | 1.56B |
- Stock Market
- Equities
- PILL Stock
- TFS Stock
- Company Telferscot Resources Inc